{
    "2019-05-05": [
        [
            {
                "time": "",
                "original_text": "【西南医药】医药行业2018年年报及2019年一季报总结：行业分化明显，疫苗、CRO和药店等表现抢眼",
                "features": {
                    "keywords": [
                        "医药行业",
                        "年报",
                        "一季报",
                        "疫苗",
                        "CRO",
                        "药店"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "A股：五一归来，下周开始贪婪还是继续恐慌？",
                "features": {
                    "keywords": [
                        "A股",
                        "五一",
                        "贪婪",
                        "恐慌"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【国盛医药张金洋团队】年报季报验证医药从野蛮扩张到结构优化，继续推荐医药流通",
                "features": {
                    "keywords": [
                        "医药",
                        "年报",
                        "季报",
                        "结构优化",
                        "医药流通"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "云南白药2019年一季报点评:利润增速符合预期,药品板块短期压力较大",
                "features": {
                    "keywords": [
                        "云南白药",
                        "一季报",
                        "利润增速",
                        "药品板块",
                        "短期压力"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}